Skip to main content
Caplight Logo









MedAll

MedAll

Private
BelfastHealthcare & Life Scienceshttps://medall.org/

Last Round

Seed

Jan 5, 2022

Total Funding Raised

$4.3M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

MedAll is a healthtech company that operates a virtual and hybrid training platform for healthcare professionals and students to access educational content, conferences, and career resources.

Sector

Healthcare & Life Sciences

Verticals

Vertical SaaS, Event Management, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Payment Processing Fee, Data as a Service

AI Layer

Application

Keywords

medical education platformcontinuing professional developmentCPDvirtual medical traininghealthcare SaaSmedical webinar platformaccreditation managementhealthcare analyticsmedical event managementedtech for healthcaremedtechHCP engagementvirtual learning environmentprofessional medical associations

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MedAll Comparables

Compare MedAll with similar companies based on industry and business-model similarity.

MedAll comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Oasis LMS
78%
Cadmium
76%
HealthStream
71%

MedAll Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 5, 2022
Pre SeedJun 5, 2020

Key People

Founding team and executive leadership

Phil McElnay

CEO

Executive Team

MedAll Investors

Notable investors and investment history

MedAll investors
InvestorRounds
Ascension VenturesPre Seed, Seed
Nina CapitalSeed
Connect VenturesSeed
Techstart VenturesPre Seed, Seed
SeedcampSeed, Pre Seed
Ascension VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 14, 2026

    Named one of Europe's fastest-growing companies by Sifted and the Financial Times.

  • Jan 14, 2026

    Technology now used for virtual training in 171 countries.

MedAll Filings

Explore SEC and related filing metadata, where available.

MedAll filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about MedAll's valuation, stock price, and market status.

Is MedAll a public or private company?

MedAll is a private company.

What is the current stock price of MedAll?

MedAll is a private company with no public stock price. No recent secondary market data is available.

How much is MedAll worth (valuation)?

Valuation information for MedAll is not publicly available.

Can I buy MedAll stock?

MedAll shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was MedAll's last funding round?

MedAll's most recent funding round was Seed on January 5, 2022.

Who are the main investors in MedAll?

Key investors in MedAll include Connect Ventures.

Will MedAll IPO soon?

No public IPO plans have been announced for MedAll.

How can I track MedAll secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MedAll's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBelfast
Employee Range24
Year Founded2017
Last FundingJan 5, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?